tiprankstipranks
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (SMMBF)
OTHER OTC:SMMBF
US Market
SMMBF
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
RESEARCH TOOLSreports

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (SMMBF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SMMBF Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Shanghai
MicroPort MedBot (Group) Co., Ltd. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SMMBF Stock 12 Month Forecast

Average Price Target

$5.08
▲(35.50% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H in the last 3 months. The average price target is $5.08 with a high forecast of $5.35 and a low forecast of $4.66. The average price target represents a 35.50% change from the last price of $3.75.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","6":"$6","1.5":"$1.5","4.5":"$4.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.352648,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.08119228,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.664450400000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.66</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.5,3,4.5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.8732806153846155,3.9965612307692306,4.119841846153847,4.243122461538461,4.366403076923077,4.489683692307692,4.612964307692308,4.7362449230769235,4.859525538461538,4.982806153846154,5.106086769230769,5.229367384615385,{"y":5.352648,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.8523994061538462,3.9547988123076925,4.057198218461538,4.159597624615385,4.261997030769231,4.3643964369230765,4.466795843076923,4.569195249230769,4.671594655384615,4.7739940615384615,4.876393467692307,4.978792873846154,{"y":5.08119228,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.8203423384615385,3.890684676923077,3.9610270153846154,4.031369353846154,4.101711692307693,4.172054030769231,4.24239636923077,4.312738707692308,4.383081046153847,4.453423384615385,4.523765723076924,4.594108061538462,{"y":4.664450400000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5.35Average Price Target$5.08Lowest Price Target$4.66
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on SMMBF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$5.35
Buy
42.74%
Upside
Reiterated
07/27/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from J.P. Morgan
UBS Analyst forecast on SMMBF
Unknown Analyst
UBS
Not Ranked
UBS
$4.58→$4.66
Buy
24.39%
Upside
Reiterated
07/23/26
UBS Remains a Buy on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
DBS Analyst forecast on SMMBF
Nico Chen
DBS
DBS
―
Buy
―
Reiterated
07/23/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from DBS
Citi Analyst forecast on SMMBF
Unknown Analyst
Citi
Not Ranked
Citi
$5.23
Buy
39.34%
Upside
Reiterated
07/21/26
Citi Keeps Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
Guotai Haitong Analyst forecast on SMMBF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$5.08
Buy
35.53%
Upside
Reiterated
05/27/26
Guotai Haitong Sticks to Their Buy Rating for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
Citic Securities Analyst forecast on SMMBF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$4.33
Buy
15.55%
Upside
Reiterated
05/12/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from Citic Securities
Goldman Sachs Analyst forecast on SMMBF
Chris Pan
Goldman Sachs
Goldman Sachs
$5.73
Buy
52.93%
Upside
Initiated
04/21/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Initiated with a Buy at Goldman Sachs
Jefferies Analyst forecast on SMMBF
David Shang
Jefferies
Jefferies
$5.1
Buy
35.94%
Upside
Reiterated
03/30/26
Jefferies Sticks to Its Buy Rating for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
SPDB Analyst forecast on SMMBF
Unknown Analyst
SPDB
Not Ranked
SPDB
$3.02
Sell
-19.46%
Downside
Reiterated
09/03/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on SMMBF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$5.35
Buy
42.74%
Upside
Reiterated
07/27/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from J.P. Morgan
UBS Analyst forecast on SMMBF
Unknown Analyst
UBS
Not Ranked
UBS
$4.58→$4.66
Buy
24.39%
Upside
Reiterated
07/23/26
UBS Remains a Buy on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
DBS Analyst forecast on SMMBF
Nico Chen
DBS
DBS
―
Buy
―
Reiterated
07/23/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from DBS
Citi Analyst forecast on SMMBF
Unknown Analyst
Citi
Not Ranked
Citi
$5.23
Buy
39.34%
Upside
Reiterated
07/21/26
Citi Keeps Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
Guotai Haitong Analyst forecast on SMMBF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$5.08
Buy
35.53%
Upside
Reiterated
05/27/26
Guotai Haitong Sticks to Their Buy Rating for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
Citic Securities Analyst forecast on SMMBF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$4.33
Buy
15.55%
Upside
Reiterated
05/12/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from Citic Securities
Goldman Sachs Analyst forecast on SMMBF
Chris Pan
Goldman Sachs
Goldman Sachs
$5.73
Buy
52.93%
Upside
Initiated
04/21/26
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Initiated with a Buy at Goldman Sachs
Jefferies Analyst forecast on SMMBF
David Shang
Jefferies
Jefferies
$5.1
Buy
35.94%
Upside
Reiterated
03/30/26
Jefferies Sticks to Its Buy Rating for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
SPDB Analyst forecast on SMMBF
Unknown Analyst
SPDB
Not Ranked
SPDB
$3.02
Sell
-19.46%
Downside
Reiterated
09/03/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
IMRXImmuneering
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

3 Months
David ShangJefferies
Success Rate
1/4 ratings generated profit
25%
Average Return
+6.05%
Copying David Shang's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +6.05% per trade.
1 Year
David ShangJefferies
Success Rate
1/4 ratings generated profit
25%
Average Return
+3.98%
Copying David Shang's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +3.98% per trade.
2 Years
David ShangJefferies
Success Rate
1/4 ratings generated profit
25%
Average Return
+5.95%
Copying David Shang's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of +5.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SMMBF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
3
2
4
3
Buy
3
5
4
4
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
8
6
8
5
In the current month, SMMBF has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SMMBF average Analyst price target in the past 3 months is 5.08.
Each month's total comprises the sum of three months' worth of ratings.

SMMBF Financial Forecast

SMMBF Earnings Forecast

Next quarter’s earnings estimate for SMMBF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was -$0.02. SMMBF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SMMBF has Performed in-line its overall industry.
Next quarter’s earnings estimate for SMMBF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was -$0.02. SMMBF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SMMBF has Performed in-line its overall industry.

SMMBF Sales Forecast

Next quarter’s sales forecast for SMMBF is $82.13M with a range of $82.13M to $82.13M. The previous quarter’s sales results were $52.37M. SMMBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SMMBF has Performed in-line its overall industry.
Next quarter’s sales forecast for SMMBF is $82.13M with a range of $82.13M to $82.13M. The previous quarter’s sales results were $52.37M. SMMBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SMMBF has Performed in-line its overall industry.

SMMBF Stock Forecast FAQ

What is SMMBF’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s 12-month average price target is 5.08.
    What is SMMBF’s upside potential, based on the analysts’ average price target?
    Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has 35.50% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SMMBF a Buy, Sell or Hold?
          Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s price target?
            The average price target for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is 5.08. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $5.35 ,the lowest forecast is $4.66. The average price target represents 35.50% Increase from the current price of $3.75.
              What do analysts say about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H?
              Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of SMMBF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.